NCT00217542
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Yale University New Haven, Connecticut, United States
Clinical trial condition
Nevi and Melanomas
Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.
2,363 public trials
405 recruiting studies
Nevi and Melanomas trial results
Completed
Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00112476
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT00006368
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Immunotherapy of Melanoma Patients
NCT00112216
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland
NCT00112229
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland
NCT00004184
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
Not specified
NCT00085423
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT00568048
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Kantonsspital Graubuenden Chur, Switzerland
Completed
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
NCT00238329
- Conditions
- Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States